S&P 500

5.475,09

0,27%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

NVEC NVE Corporation

72,30

-2,39 (-3,20%)

02 Jul 2024 - Geschlossen

Verzögert um 15 Minuten

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

null

NVE (NASDAQ:NVEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

NVE (NASDAQ:NVEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024

News NVE Corporation

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 17 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 12 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 11 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results
Mittwoch 24 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 13 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 7 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 27 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 24 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 17 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 17 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere NVE Corporation News-Artikel

NASDAQ

HBIO

Harvard Bioscience

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NVEC NVE Corporation

News NVE Corporation

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NVEC NVE Corporation

News NVE Corporation

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen